Microinjection of 8-OH-DPAT into nucleus accumbens attenuates naloxone-induced morphine withdrawal syndrome.
Dzoljic
M R
MR
Department of Pharmacology, Faculty of Medicine and Health Sci., Erasmus University, Rotterdam, The Netherlands.
v Ent
M
M
Kaplan
C D
CD
Saxena
P R
PR
D017371:8-Hydroxy-2-(di-n-propylamino)tetralin; D000818:Animals; D008297:Male; D008845:Microinjections; D009020:Morphine / Q000633:toxicity*; D009270:Naloxone / Q000494:pharmacology; D009281:Naphthalenes / Q000494:pharmacology*; D009714:Nucleus Accumbens / Q000187:drug effects* / Q000503:physiopathology; D051381:Rats; D011919:Rats, Inbred Strains; D011985:Receptors, Serotonin / Q000187:drug effects / Q000502:physiology; D012686:Septal Nuclei / Q000187:drug effects*; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy* / Q000503:physiopathology; D013764:Tetrahydronaphthalenes / Q000008:administration & dosage / Q000494:pharmacology*
D009281:Naphthalenes; D011985:Receptors, Serotonin; D013764:Tetrahydronaphthalenes; D009270:Naloxone; D009020:Morphine; D017371:8-Hydroxy-2-(di-n-propylamino)tetralin